Explore › Outcome › Serious adverse events
Outcome

Serious adverse events

Also known as: Serious adverse events
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
Bilateral deep sclerectomy1
conditions
advanced Parkinson disease with motor complications1
populations
Older Adults1
studys
PMC28148001

Findings (27)

None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →
None
adverse

The overall incidence risk of experiencing a serious adverse event was 3.8 times higher in DBS patients than in BMT patients, with 49 DBS patients (40%) experiencing at least 1 serious adverse event c

Effect: adverse; Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients vs 11% of BMT patients experienced at least 1 serious adverse event; CI: 95% CI, 2

Size: Incidence risk ratio 3.8 (DBS vs BMT); 40% of DBS patients v CI: 95% CI, 2.3-6.3
PMC2814800
Finding details → · Paper → · Graph →

Papers (1)